Rakuten Medical
BiotechnologyView the employees at
Rakuten Medical-
Karen Rodriguez Sr Associate II, Analytical Formulation Development at Rakuten Medical
-
San Diego County, California, United States
-
Rising Star
Shiou-Yi Ethan Chen Medical Director at Rakuten Medical-
Taipei City, Taipei City, Taiwan
-
Top 10%
Hiroyuki Kodama VP of Device Technology & Solutions, Japan Office Co-head, Managing Director Rakuten Medical Europe BV-
Tokyo, Japan
-
Top 10%
Patrick Rostrata Logistics and Transportation Consultant at PCI Portal, Inc.-
Milpitas, California, United States
-
Rising Star
Devinda Rukshan Wijenayake Information Technology Manager at Rakuten Medical Japan-
Tokyo, Tokyo, Japan
-
Rising Star
Overview
Rakuten Medical, Inc. is a global biotechnology company developing and commercializing precision, cell-targeting investigational therapies on its AlluminoxTM platform, which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis. Outside of Japan, Alluminox therapies have not yet been approved as safe or effective by any regulatory authority. The company’s first drug developed on the Alluminox platform, ASP-1929, has received approval from the Japanese Ministry of Health, Labour, and Welfare, and is currently the subject of a global phase 3 clinical trial for recurrent head and neck cancer. Rakuten Medical is committed to its mission to conquer cancer by delivering our innovative treatments as quickly and safely as possible to as many patients all over the world as possible. The company has locations in 6 countries, including the United States, where it is headquartered, Japan, Taiwan, the Netherlands, Switzerland and India. For more information, visit www.rakuten-med.com.
-